Pharmaceutical Investing SELLAS Life Sciences Group and Cancer Center to Study Galinpepimut-S in Combination with Nivolumab in Patients with Malignant Pleural Mesothelioma
SELLAS Life Sciences Announces Additional Positive Triple Negative Breast Cancer (TNBC) Subgroup Data
SELLAS Life Sciences Announces Settlement of Counterclaims Against JGB (Cayman) Newton for $6.6 Million Payment by JGB
SELLAS Life Sciences Announces Positive Final Data in Triple Negative Breast Cancer Patients from Phase 2b Clinical Trial of Nelipepimut-S
SELLAS Receives Orphan Medicinal Product Designation Approval by the Committee for Orphan Medicinal Products of the European Medicines Agency
Grande Portage Stakes Added Claims to Accommodate Potential Surface Facilities at the New Amalga Gold Project
Blue Lagoon Resources to Showcase Dome Mountain Gold Project at 121 Mining Investment Conference in London
American Salars Starts Sampling at 100% Owned Brazilian LCT Pegmatite Project, with Past Samples Hitting 3.72% Li2o and Significant Ree Values
